Importance of intra-therapy single-photon emission tomographic imaging in calculating tumour dosimetry for a lymphoma patient

Kenneth F. Koral, Kenneth R. Zasadny, Fayez M. Swailem, Steven F. Buchbinder, Isaac R. Francis, Mark S. Kaminski, Richard L. Wahl

Research output: Contribution to journalArticlepeer-review

8 Scopus citations


The dosimetry for two, similarly sized tumours in a lymphoma patient being treated with non-bone marrow ablative, monoclonal antibody therapy is reported. The 45-year-old man was infused with 2.48 GBq (67 mCi) of131I-labelled MB-1. Prior to therapy, a time series of diagnostic conjugate-view images and a radionuclide transmission scan were obtained and processed to obtain time-activity curves. Starting 2 days after the therapeutic infusion of radioactivity, a second conjugate-view time series was obtained. At that time, a quantitative single-photon emission tomography (SPET) acquisition was also carried out. Pre- and post-therapy X-ray computed tomography scans demonstrated a percentage reduction in volume for the right tumour which was 3.8 times that for the left tumour. In contrast, diagnostic conjugate views by themselves estimated the absorbed dose to be the same for the two tumours. Addition of therapy conjugate-view data increased the right-over-left ratio but only to 1.22. Normalizing either time-activity series by the intra-therapy SPET results increased the ratio to greater than 1.5. We assume here that a differential dose is correct according to the differential tumour shirnkage. One can further assume that the largest ratio corresponds most certainly to the most accurate dosimetric method. Other assumptions are possible. While additional study is essential, data from this patient suggest that the preferred dosimetric method is intra-therapy SPET normalization of either time series.

Original languageEnglish
Pages (from-to)432-435
Number of pages4
JournalEuropean Journal of Nuclear Medicine
Issue number6
StatePublished - Jun 1991


  • Lymphoma
  • Monoclonal antibody
  • Radionuclide therapy
  • Single-photon emission tomography (SPET) quantification
  • Tumour dosimetry


Dive into the research topics of 'Importance of intra-therapy single-photon emission tomographic imaging in calculating tumour dosimetry for a lymphoma patient'. Together they form a unique fingerprint.

Cite this